1-7 of 7
Dietmar Pils
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3997: TUSC3 (N33) affects protein N-glycosylation and proliferation of prostate cancer cells

Peter Horak, Erwin Tomasich, Mariam Anees, Maximilian Marhold, Marion Gerschpacher, Dietmar Pils, Michael Krainer
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3997.
https://doi.org/10.1158/1538-7445.AM2012-3997
Published: 15 April 2012
View article titled, Abstract 3997: TUSC3 (N33) affects protein N-glycosylation and proliferation of prostate cancer cells
Journal Articles

HCRP1 contributes to degradation of activated EGFR, a mechanism highly relevant for ovarian cancer

Michael Wittinger, Dietmar Pils, Ahmed El-Gazzar, Robert Zeillinger, Thomas Grunt, Michael Krainer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3427.
Published: 01 May 2008
View article titled, HCRP1 contributes to degradation of activated EGFR, a mechanism highly relevant for ovarian cancer
Journal Articles

Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers

Lin Li, Stephan Ryser, Eva Dizin, Dietmar Pils, Michael Krainer, Charles Edward Jefford, Francesco Bertoni, Robert Zeillinger, Irmgard Irminger-Finger
Journal: Cancer Research
Cancer Res (2007) 67 (24): 11876–11885.
https://doi.org/10.1158/0008-5472.CAN-07-2370
Published: 18 December 2007
View article titled, Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers
Open the PDF for Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers in another window
Includes: Supplementary data
Journal Articles

Whole genome screening for epigenetically silenced genes using a panel of epithelial cancer cell lines

Dietmar Pils, Brigitte Wolf, Michael Wittinger, Jochen Reibenwein, Bernd Mayer, Dominique Koensgen, Alexander Mustea, Isabelle Cadron, Toon van Gorp, Sven Mahner, Nicole Concin, Dan Cacsire-Castillo Tong, Robert Zeillinger, Michael Krainer
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 251.
Published: 01 May 2007
View article titled, Whole genome screening for epigenetically silenced genes using a panel of epithelial cancer cell lines
Journal Articles

N33 (TUSC3) promoter hypermethylation in serum of prostate cancer patients

Peter Horak, Jochen Reibenwein, Dietmar Pils, Alexey Teterin, Andreas Kirisits, Katarzyna Elandt, Sandra Tomek, Christoph C. Zielinski, Michael Krainer
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 763–764.
Published: 15 April 2006
View article titled, <em>N33 (TUSC3)</em> promoter hypermethylation in serum of prostate cancer patients
Journal Articles

Hypermethylation of N33 (TUSC3) as independent molecular predictor for ovarian cancer

Dietmar Pils, Peter Horak, Andreas Kirisits, Andreas Gleiss, Markus Omann, Alexander Pinter, Christoph Zielinski, Alexander Mustea, Dominique Koensgen, Robert Zeillinger, Michael Krainer
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 760.
Published: 15 April 2006
View article titled, Hypermethylation of <em>N33</em> (<em>TUSC3</em>) as independent molecular predictor for ovarian cancer
Journal Articles

TRAIL receptor 1 (DR4) is frequently methylated in ovarian cancer: Relevance for TRAIL sensitivity and ovarian cancer tumorigenesis

Peter Horak, Dietmar Pils, Griet Haller, Reinhard Horvath, Sandra Tomek, Robert Zeillinger, Christoph Zielinski, Michael Krainer
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 586–587.
Published: 01 May 2005
View article titled, TRAIL receptor 1 (DR4) is frequently methylated in ovarian cancer: Relevance for TRAIL sensitivity and ovarian cancer tumorigenesis